Literature DB >> 9130454

The early and late phases of ischemic preconditioning: a comparative analysis of their effects on infarct size, myocardial stunning, and arrhythmias in conscious pigs undergoing a 40-minute coronary occlusion.

Y Qiu1, X L Tang, S W Park, J Z Sun, A Kalya, R Bolli.   

Abstract

The effectiveness of the late phase of ischemic preconditioning (PC) in protecting against myocardial infarction and the concomitant contractile dysfunction after sustained ischemia remains unclear. The early and late phases of PC have not been compared using the same protocol in the same experimental model; furthermore, the late phase of PC has not been assessed in the conscious state in a large animal preparation. The goal of this study was to directly compare the effects of early and late PC on myocardial infarct size and postischemic dysfunction in chronically instrumented, conscious pigs. Four groups of pigs were subjected to a 40-minute coronary occlusion followed by 3 days of reperfusion. Group 1 (n=7) served as control. Group 2 (n=6) was subjected to ten 2-minute occlusion/2-minute reperfusion cycles 25 minutes before the 40-minute occlusion (early PC). Groups 3 (n=7) and 4 (n=4) were subjected to 10 and 25 cycles, respectively, of 2-minute occlusion/2-minute reperfusion 24 hours before the 40-minute occlusion (late PC). Infarct size averaged 45.1+/-5.9% of the region at risk in control pigs, was reduced by 79% (to 9.4+/-3.2%) in group 2, but did not differ in groups 3 (33.3+/-4.8%) and 4 (38.8+/-8.2%) versus group 1. Power analysis demonstrated that there was an 80% probability of detecting a 40% decrease in infarct size in groups 3 and 4 versus group 1. The recovery of systolic wall thickening (measured with ultrasonic crystals) after the 40-minute occlusion was poor in groups 1, 3, and 4 but markedly enhanced in group 2 throughout the 3 days of reperfusion; this beneficial effect could have been due to limitation of infarct size, alleviation of stunning, or both. Thus, a series of ten 2-minute coronary occlusions had a profound (approximately 80%) early infarct-limiting effect, which was associated with a marked functional benefit. This protection, however, disappeared 24 hours later and could not be reinstituted by increasing the number of PC coronary occlusions to 25. The incidence and duration of ventricular tachycardia after reperfusion was not changed by either early or late PC; no conclusions could be drawn regarding ventricular fibrillation or ischemia-induced ventricular tachycardia, since these arrhythmias did not occur in control animals. Taken together, the present results demonstrate striking differences between the early and late effects of PC: In conscious swine subjected to a sustained coronary occlusion, a PC protocol that induces powerful protection during the early phase of PC fails to induce any protection during the late phase, indicating either that a late protective effect of PC does not exist or that, if it exists, it must be weaker than the early protective effect.

Entities:  

Mesh:

Year:  1997        PMID: 9130454     DOI: 10.1161/01.res.80.5.730

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  11 in total

Review 1.  Therapeutic potential of ischaemic preconditioning.

Authors:  R J Edwards; A T Saurin; R D Rakhit; M S Marber
Journal:  Br J Clin Pharmacol       Date:  2000-08       Impact factor: 4.335

Review 2.  Coronary vasoregulation in health and disease.

Authors:  John G Kingma; Jacques R Rouleau
Journal:  Can J Cardiol       Date:  2007-10       Impact factor: 5.223

3.  Pharmacological delayed preconditioning against ischaemia-induced ventricular arrhythmias: effect of an adenosine A(1)-receptor agonist.

Authors:  R Tissier; R Souktani; O Parent de Curzon; N Lellouche; P Henry; J F Giudicelli; A Berdeaux; B Ghaleh
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

4.  Ischemic preconditioning may be transferable via whole blood transfusion: preliminary evidence.

Authors:  E W Dickson; C P Reinhardt; F P Renzi; R C Becker; W A Porcaro; S O Heard
Journal:  J Thromb Thrombolysis       Date:  1999-08       Impact factor: 2.300

Review 5.  Effects of brief ischemia and reperfusion on the myocardium and the role of nitric oxide.

Authors:  Christopher S R Baker; Sanjay Kumar; Ornella E Rimoldi
Journal:  Heart Fail Rev       Date:  2003-04       Impact factor: 4.214

6.  Demonstration of an early and a late phase of ischemic preconditioning in mice.

Authors:  Y Guo; W J Wu; Y Qiu; X L Tang; Z Yang; R Bolli
Journal:  Am J Physiol       Date:  1998-10

Review 7.  Nitric oxide and cardiovascular protection.

Authors:  Bodh I Jugdutt
Journal:  Heart Fail Rev       Date:  2003-01       Impact factor: 4.214

8.  Novel cardioprotective strategy combining three different preconditioning methods to prevent ischemia/reperfusion injury in aged hearts in an improved rabbit model.

Authors:  Jian-Xi Ye; Dao-Zhong Chen
Journal:  Exp Ther Med       Date:  2015-08-13       Impact factor: 2.447

Review 9.  Dioxygen and Metabolism; Dangerous Liaisons in Cardiac Function and Disease.

Authors:  Aude Angelini; Xinchun Pi; Liang Xie
Journal:  Front Physiol       Date:  2017-12-12       Impact factor: 4.566

10.  The COX-2/PGI2 receptor axis plays an obligatory role in mediating the cardioprotection conferred by the late phase of ischemic preconditioning.

Authors:  Yiru Guo; Deepali Nivas Tukaye; Wen-Jian Wu; Xiaoping Zhu; Michael Book; Wei Tan; Steven P Jones; Gregg Rokosh; Shuh Narumiya; Qianhong Li; Roberto Bolli
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.